Company Overview Almirall is an international pharmaceutical company based on innovation and committed to health, whose headquarters is located in Barcelona (Spain). Almirall researches, develops, produces and markets own R&D and licensed drugs with the aim of improving the health and quality of life of patients.
The company started its activity in the United Kingdom and Ireland at the beginning of 2008,with the aim of strengthening its European presence.
Almirall's British affiliate, Almirall Ltd., is focused on the marketing of dermatology products and was formed after the acquisition of Hermal, a company specialising in dermatology. Hermal already had distribution and a small sales force in the UK. Almirall followed this by the purchase of a product portfolio from Shire. Product OverviewThe company's principal goal is to provide society with innovative medicines which contribute to improving the health and quality of life for people all over the world. The following company products are the result of Almirall's Research & Development: - Almotriptan
- Ebastine
- Aceclofenac
- Almagate
- Piketoprofen
- Cinitapride
- Clebopride
These products are present in over 80 countries, either by Almirall's own marketing or through licensee companies.
| 
